Trade

TTK Healthcare share price

Balanced risk
  • 25%Low risk
  • 25%Moderate risk
  • 25%Balanced risk
  • 25%High risk
  • 25%Extreme risk
  • 994.20(-0.05%)
    January 14, 2026 14:41:31 PM IST
    • NSE
    • BSE
  • Vol : 1.20 K (NSE + BSE)
    Last 20 day avg : 5.41 K

TTK Healthcare is trading -0.05% lower at Rs 994.20 as compared to its last closing price. TTK Healthcare has been trading in the price range of 995.70 & 991.00. TTK Healthcare has given -4.92% in this year & -2.27% in the last 5 days. TTK Healthcare has TTM P/E ratio 24.57 as compared to the sector P/E of 22.78.The company posted a net profit of 20.39 Crores in its last quarter.Listed peers of TTK Healthcare include Divi's Laboratories (-1.29%), Cipla (-0.90%), Sun Pharmaceutical Industries (-1.69%).The Mutual Fund holding in TTK Healthcare was at 0.04% in 30 Jun 2025. The MF holding has decreased from the last quarter. The FII holding in TTK Healthcare was at -% in . The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Jan 15, 2026, 05:35 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.44
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.02
    In line with industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    1.01
    Inline with the industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    1.31
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    21.07
    Lower than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    0.33
    Indicates undervaluation
Price range
Day Range
Lowest
991.00
Highest
995.70
52 week range
Lowest
976.20
Highest
1,402.00
TTK Healthcare Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Divi's Laboratories
Neutral
6,350.50-1.291,68,751.7478.6111.520.460.01
Cipla
Bearish
1,434.60-0.901,15,882.9422.953.870.870.81
Sun Pharmaceutical Industries
Neutral
1,700.55-1.694,08,009.3036.245.770.920.50
Dr Reddy's Laboratories
Bearish
1,187.70-0.2299,020.0918.633.140.632.34
Torrent Pharmaceuticals
Bullish
4,003.251.621,35,536.8867.3217.10.8317.62
Mutual Fund Ownership
View all
ITI Pharma and Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 0.71
  • % of AUM 0.32
TTK Healthcare Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-01-22Quarterly Results & Others
2025-10-17Quarterly Results
2025-08-04Quarterly Results
2025-05-23Audited Results & Final Dividend
2025-01-24Quarterly Results & Others
About the company TTK Healthcare
  • IndustryBiotechnology & Drugs
  • ISININE910C01018
  • BSE Code507747
  • NSE CodeTTKHLTCARE
TTK Healthcare Limited is an India-based company providing consumer and healthcare products. The Company's segments include Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, and Others. The Animal Welfare segment offers products for veterinary use, including the brands Ossomin, Orcal-P, Epidosin, and others. The Consumer Products segment markets and distributes Woodward's Gripe Water, the EVA range of cosmetics, the Good Home range of scrubbers, air fresheners, and various other products. The Medical Devices segment includes the manufacturing and marketing of artificial heart valves, orthopedic implants, and others. The Protective Devices segment focuses on manufacturing and marketing male contraceptives and related products. The Foods segment involves the manufacturing and marketing of food products. Extruded products, such as papads, are offered under the brand name Fryums. The Others segment includes the printing and publishing of maps and atlases.
  • Management Info
  • S. KalyanaramanChief Executive Officer, Managing Director, Executive Director
  • T. RaghunathanExecutive Vice Chairman of the Board
  • B. V. K. Durga PrasadChief Financial Officer, President - Finance
  • Gowry JaishankarCompliance Officer, Company Secretary
TTK Healthcare Share Price FAQs

TTK Healthcare is trading at 994.20 as on Wed Jan 14 2026 09:11:31. This is -0.05% lower as compared to its previous closing price of 994.65.

The market capitalization of TTK Healthcare is 1395.58 Cr as on Wed Jan 14 2026 09:11:31.

The 52 wk high for TTK Healthcare is 1402.00 whereas the 52 wk low is 976.20

TTK Healthcare can be analyzed on the following key metrics -

  • TTM P/E: 24.57
  • Sector P/E: 22.78
  • Dividend Yield: 1.01%
  • D/E ratio: 0.02

TTK Healthcare reported a net profit of 81.66 Cr in 2025.

The Mutual Fund Shareholding was 0.04% at the end of 30 Jun 2025.